Business Context and Reporting Period
Company: Pinnacle Food Group Ltd (PFAI)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal Year Ended December 31, 2025
Jurisdiction: Incorporated in Cayman Islands; Principal operations in Canada and Hong Kong.
Business Overview: Pinnacle Food Group is a provider of smart farming solutions (Farming as a Service or "FaaS") and an emerging participant in bio-engineering. The company sells hydroponic growing systems, construction services, and consulting. In 2025, the company shifted focus from individual households to commercial and enterprise clients. It also initiated bio-engineering activities, including precision fermentation for recombinant human lactoferrin (rhLF).
Key Financial Metrics
| Metric | 2025 (US$) | 2024 (US$) |
|---|---|---|
| Revenue | 3,413,062 | 3,289,862 |
| Cost of Revenues | 2,107,101 | 1,734,344 |
| Gross Profit | 1,305,961 | 1,555,518 |
| Gross Margin | 38.3% | 47.3% |
| Operating Expenses | 3,227,906 | 940,682 |
| Net Loss | (1,903,908) | 286,142 (Income) |
| Cash and Cash Equivalents (End of Period) | 942,820 | 685,796 |
| Current Liabilities | 2,415,329 | 2,903,760 |
| Working Capital | 2,906,225 (Surplus) | 999,652 (Surplus) |
| Accumulated Deficit | (1,083,121) | 820,787 (Retained Earnings) |
Debt: As of December 31, 2025, the company held a secured bank loan with a principal balance of approximately US$1.0 million (4.77% fixed interest, maturing September 2027). The loan is secured by land and buildings and guaranteed by a director.
Material Changes vs. Prior Period
- Profitability Reversal: The company swung from a net income of US$0.3 million in 2024 to a net loss of US$1.9 million in 2025. This was driven by a 243% increase in operating expenses (from US$0.94M to US$3.23M) due to increased advertising, salaries, travel, and R&D costs.
- Revenue Composition: While total revenue grew slightly (3.7%), the mix shifted significantly. Commercial and enterprise customers accounted for 59% of revenue in 2025, compared to a distributor-heavy model in 2024. Construction services and consulting services became significant revenue streams.
- Margin Compression: Gross margin declined from 47% to 38% due to higher payroll expenses and construction costs outpacing revenue growth in those segments.
- Cash Flow: Operating cash flow turned negative, with a net use of US$3.6 million in 2025, compared to a positive US$0.2 million in 2024. This was primarily due to the net loss and a US$1.2 million increase in accounts receivable.
- Capital Structure: The company completed an IPO in April 2025, raising gross proceeds of approximately US$7.2 million. Financing activities provided US$6.7 million in net cash in 2025.
Guidance, Outlook, Risks, and Contingencies
Going Concern Warning
The filing explicitly states there is substantial doubt regarding the company's ability to continue as a going concern. Management expects operating losses to continue for the foreseeable future. The company has an accumulated deficit of US$1.1 million and relies on additional capital resources (debt or equity) to meet working capital requirements. There is no assurance that financing will be available on acceptable terms.
Outlook and Strategy
- Bio-Engineering Expansion: The company is investing in bio-engineering, specifically precision fermentation for rhLF. A collaboration with Bioboost involves milestone-based payments totaling approximately US$580,000 over 18 months. These initiatives are at an early stage with no assurance of commercial viability.
- Technology Development: The company has a remaining contractual obligation of US$1.45 million for AI software and hardware integration services.
- Market Expansion: Plans include expanding sales to new jurisdictions and increasing marketing efforts, which will require significant capital.
Key Risks
- Internal Controls: A material weakness was identified in internal control over financial reporting due to a lack of sufficient personnel with U.S. GAAP expertise.
- Supply Chain: Reliance on third-party OEM manufacturers (Banjia, Seonwo) in China without long-term supply agreements exposes the company to supply disruptions and price fluctuations.
- Intellectual Property: The company relies on a proxy arrangement where a Chinese manufacturer holds a design patent on its behalf, creating enforcement risks.
- Regulatory: Operations in Hong Kong and China expose the company to geopolitical risks, including the Hong Kong National Security Law and potential U.S. sanctions.
Investor Verification Checklist
- Going Concern Status: Verify the company's ability to secure additional financing to cover the US$1.9M net loss and negative operating cash flow.
- Accounts Receivable: Review the aging of the US$4.15M accounts receivable balance, noting that 28% was due from distributors with 180-day credit terms as of year-end.
- Related Party Transactions: Scrutinize the US$1.3M purchase of land and buildings from a related party (Steel Magnolia Investment Ltd, owned by the Chairman) and the US$171k consulting agreement with VSH Services Inc.
- Internal Control Remediation: Assess the progress of hiring qualified accounting personnel to remediate the identified material weakness in financial reporting.
- Bio-Engineering Viability: Evaluate the technical and regulatory risks associated with the early-stage bio-engineering initiatives and the US$580k milestone payments to Bioboost.
- Contractual Obligations: Confirm the status of the US$1.45M outstanding payable for AI software development and the US$1.0M bank loan covenants.